Stephanie Kennan on Pharmaceutical Industry

Washington Healthcare Update - June 2021 #1

Congress - House and Senate are in recess for two weeks. Senate - Brooks-LaSure Confirmed as CMS Administrator - On May 25, the Senate voted 55-44 to confirm Chiquita Brooks-LaSure as the Centers for Medicare...more

6/2/2021 / Centers for Medicare & Medicaid Services (CMS) , Department of Health and Human Services (HHS) , Food and Drug Administration (FDA) , GAO , Medicaid , Medical Devices , Pharmaceutical Industry , Proposed Rules , Skilled Nursing Facility

Washington Healthcare Update - May 2021 #2

This week in Washington: Biden Administration expresses support for WTO TRIPS Waiver....more

5/11/2021 / Centers for Medicare & Medicaid Services (CMS) , Department of Health and Human Services (HHS) , Food and Drug Administration (FDA) , GAO , Hospitals , MACPAC , Pharmaceutical Industry , Prescription Drugs , Proposed Rules , Skilled Nursing Facility

Washington Healthcare Update - May 2021 #1

This week in Washington: President Biden Announces American Families Plan Vision in Speech to Joint Session of Congress....more

5/4/2021 / Biden Administration , Centers for Disease Control and Prevention (CDC) , Centers for Medicare & Medicaid Services (CMS) , Department of Health and Human Services (HHS) , Drug Pricing , Food and Drug Administration (FDA) , GAO , Pharmaceutical Industry , Vaccinations

Washington Healthcare Update - April 2021 #3

This week in Washington: Andrea Palm’s nomination for HHS Deputy Secretary Advances out of Senate Finance Committee, Chiquita Brooks-LaSure’s nomination deadlocked....more

4/27/2021 / Affordable Care Act , Centers for Medicare & Medicaid Services (CMS) , Department of Health and Human Services (HHS) , Drug Pricing , Food and Drug Administration (FDA) , GAO , Medicare , Pharmaceutical Industry , Prescription Drugs , Proposed Rules , Skilled Nursing Facility

Washington Healthcare Update - April 2021 #2

This week in Washington: President sends budget request to Congress. ...more

4/20/2021 / Centers for Medicare & Medicaid Services (CMS) , Department of Health and Human Services (HHS) , Food and Drug Administration (FDA) , GAO , Medicare , Pharmaceutical Industry , Skilled Nursing Facility

Washington Healthcare Update - March 2021 #4

This week in Washington: Becerra confirmed 50-49 to be Secretary of Health and Human Services...more

3/23/2021 / Centers for Medicare & Medicaid Services (CMS) , Coronavirus/COVID-19 , Department of Health and Human Services (HHS) , Drug Pricing , Emergency Use Authorization (EUA) , Food and Drug Administration (FDA) , GAO , Medicare Part D , Nursing Homes , Pharmaceutical Industry , Prescription Drugs , Vaccinations

Washington Healthcare Update - March 2021 #1

This week in Washington: The House votes on budget reconciliation while the Senate ponders the Byrd Rule; Senate committees hold hearings on HHS Secretary-designate Becerra’s confirmation....more

3/2/2021 / Centers for Medicare & Medicaid Services (CMS) , Coronavirus/COVID-19 , Department of Health and Human Services (HHS) , Food and Drug Administration (FDA) , GAO , Health Care Providers , Pharmaceutical Industry , Supply Chain , Vaccinations

Washington Healthcare Update - February 2021 #2

This week in Washington: Congress moves towards budget reconciliation....more

2/9/2021 / Centers for Medicare & Medicaid Services (CMS) , Coronavirus/COVID-19 , Department of Health and Human Services (HHS) , Food and Drug Administration (FDA) , GAO , Medicaid , Pharmaceutical Industry , Vaccinations

Washington Healthcare Update - January 2021 #3

This week in Washington: President Joe Biden begins his term and Congress begins work to confirm cabinet secretaries....more

1/26/2021 / Centers for Medicare & Medicaid Services (CMS) , Department of Health and Human Services (HHS) , Food and Drug Administration (FDA) , GAO , Medicare , Pharmaceutical Industry , Pharmacy Benefit Manager (PBM) , Prescription Drugs

Washington Healthcare Update - January 2021 #2

This week in Washington: The 117th Congress will be in session on Jan. 21. Senate- Senate Finance Issues Bipartisan Report on Rising Insulin Prices...more

1/20/2021 / Centers for Medicare & Medicaid Services (CMS) , Coronavirus/COVID-19 , Food and Drug Administration (FDA) , GAO , Medicare Part D , Pharmaceutical Industry

Washington Healthcare Update - December 2020 #3

This week in Washington: Washington waited for a COVID-19 stimulus and omnibus appropriations bill ahead of the holiday recess, and a deal was struck Sunday night; Attached to the COVID-19 relief provisions and omnibus...more

12/22/2020 / Centers for Medicare & Medicaid Services (CMS) , Coronavirus/COVID-19 , Food and Drug Administration (FDA) , Health Care Providers , Medicaid , Pharmaceutical Industry , Vaccinations

Washington Healthcare Update - December 2020 #2

This week in Washington: Congress passes funding bill for an additional week to come up with full-year spending legislation to avoid a government shutdown....more

12/15/2020 / Centers for Medicare & Medicaid Services (CMS) , Department of Health and Human Services (HHS) , Drug Pricing , Food and Drug Administration (FDA) , GAO , Health Care Providers , Medicaid , Pharmaceutical Industry , Prescription Drugs , Section 340B

Washington Healthcare Update - October 2020 #4

This week in Washington: Mnuchin and Pelosi continue discussions for COVID-19 stimulus package....more

10/27/2020 / Centers for Medicare & Medicaid Services (CMS) , Coronavirus/COVID-19 , Department of Health and Human Services (HHS) , Food and Drug Administration (FDA) , GAO , Health Care Providers , HRSA , Pharmaceutical Industry , Section 340B , Vaccinations

Washington Healthcare Update - October 2020 #3

House - Democrats Ask GAO to Investigate Legality of President Trump’s Medicare Drug Gift Cards - On Oct. 13, House Energy & Commerce Chair Frank Pallone (D-NJ), House Ways & Means Chair Richard Neal (D-MA) and Senate...more

10/20/2020 / Centers for Medicare & Medicaid Services (CMS) , Coronavirus/COVID-19 , Department of Health and Human Services (HHS) , Drug Pricing , Food and Drug Administration (FDA) , Medicare , Pharmaceutical Industry , Prescription Drugs , Section 340B , Trump Administration , Vaccinations

Washington Healthcare Update - October 2020 #2

This week in Washington: Negotiations for COVID-19 stimulus package are ongoing; House and Senate are in recess....more

10/13/2020 / Centers for Medicare & Medicaid Services (CMS) , Coronavirus/COVID-19 , Department of Health and Human Services (HHS) , Drug Pricing , Food and Drug Administration (FDA) , GAO , Health Care Providers , Medicare , Medicare Part D , OIG , Pharmaceutical Industry , Pharmacy Benefit Manager (PBM) , Prescription Drugs , Section 340B

Washington Healthcare Update - October 2020 #1

This week in Washington: The Continuing Resolution (CR) to fund the government until Dec. 11 was signed by President Trump; House passes COVID-19 stimulus bill....more

10/6/2020 / Centers for Medicare & Medicaid Services (CMS) , Coronavirus/COVID-19 , Cost-Sharing , Department of Health and Human Services (HHS) , Department of Justice (DOJ) , Drug Pricing , Food and Drug Administration (FDA) , Healthcare Fraud , Medicaid , OMB , Pharmaceutical Industry , Telehealth , Trump Administration

Washington Healthcare Update - July 2020 #3

This week in Washington: House passes first set of Appropriations bills; President Trump signs Executive Orders on Prescription Drugs after COVID-19 bill stalled....more

7/28/2020 / Affordable Care Act , Coronavirus/COVID-19 , Defense Production Act , Department of Health and Human Services (HHS) , Food and Drug Administration (FDA) , OMB , Pharmaceutical Industry , Prescription Drugs , Right to Try

Washington Healthcare Update - June 2020 #3

This week in Washington: Senate begins considering appropriation bills and hearings on COVID-19 and health disparities continue....more

6/16/2020 / Centers for Medicare & Medicaid Services (CMS) , Coronavirus/COVID-19 , Department of Health and Human Services (HHS) , Health Care Providers , Healthcare Facilities , Medicaid , Pharmaceutical Industry

Washington Healthcare Update - April 2020 #2

This week in Washington: The Senate reconvenes April 13 to continue negotiations on the next COVID-19 stimulus package; the House is expected to reconvene April 20....more

4/14/2020 / Centers for Medicare & Medicaid Services (CMS) , Department of Health and Human Services (HHS) , Food and Drug Administration (FDA) , GAO , Pharmaceutical Industry , Telehealth , Trump Administration

Washington Healthcare Update - March 2020 #2

This week in Washington: CMS develops additional code for coronavirus lab tests, announces actions to address spread of coronavirus; House passes bill to ban e-cigarette flavors; Grassley says updated Senate Finance drug...more

3/10/2020 / Centers for Medicare & Medicaid Services (CMS) , Coronavirus/COVID-19 , Department of Health and Human Services (HHS) , Drug Pricing , E-Cigarettes , Food and Drug Administration (FDA) , GAO , Medicare Advantage , Medicare Part D , Pharmaceutical Industry

Washington Healthcare Update - March 2020 #1

This week in Washington: Hearings scheduled on the U.S. response to the Coronavirus. ...more

3/3/2020 / Biosimilars , Centers for Medicare & Medicaid Services (CMS) , Coronavirus/COVID-19 , Department of Health and Human Services (HHS) , Drug Pricing , Food and Drug Administration (FDA) , Medicaid , Medicare , Medicare Advantage , Pharmaceutical Industry

Washington Healthcare Update - January 2020 #4

This week in Washington: Both the House and Senate are back in session....more

1/28/2020 / Affordable Care Act , Centers for Medicare & Medicaid Services (CMS) , Department of Health and Human Services (HHS) , Food and Drug Administration (FDA) , GAO , Generic Drugs , Health Insurance Portability and Accountability Act (HIPAA) , Medicaid , Pharmaceutical Industry , Prescription Drugs

Washington Healthcare Update - January 2020 #3

This week in Washington: The House is not in session. The Senate will resume the impeachment trial on Tuesday....more

1/22/2020 / Centers for Medicare & Medicaid Services (CMS) , Children's Health Insurance Program (CHIP) , Drug Pricing , Food and Drug Administration (FDA) , HRSA , MACPAC , Medicare , Medicare Advantage , Pharmaceutical Industry , Trump Administration , United States-Mexico-Canada Agreement (USMCA)

Washington Healthcare Update - January 2020 #1

Wednesday, Jan. 8, 2020 - House Committee on Energy and Commerce: “Legislation to Improve Americans’ Health Care Coverage and Outcomes” - The Subcommittee on Health of the Committee on Energy and Commerce will hold a...more

1/7/2020 / Centers for Medicare & Medicaid Services (CMS) , Department of Health and Human Services (HHS) , Food and Drug Administration (FDA) , Health Care Providers , Outpatient Prospective Payment System (OPPS) , Pharmaceutical Industry , Prescription Drugs

House Passes Drug Legislation – Senate Tweaks Proposals

On Dec. 12, 2019, the U.S. House of Representatives passed HR 3, the Elijah Cummings Lower Drug Costs Now Act, which would allow the government to negotiate drug prices, among other reforms. Prior to HR 3 being considered on...more

12/18/2019 / Drug Pricing , Medicare , Medicare Part D , Pharmaceutical Industry , Prescription Drugs

Stephanie Kennan

McGuireWoods LLP

Readers' Choice Awards

Popular Topics by This Author

Latest Posts › Pharmaceutical Industry